Cart
sales@molnova.com
Palbociclib (PD0332991) Isethionate
CAS No. 827022-33-3
Palbociclib (PD0332991) Isethionate ( —— )
Catalog No. M16070 CAS No. 827022-33-3
Palbociclib (PD0332991) Isethionate is a highly selective inhibitor of CDK4/6 with IC50 of 11 nM/16 nM.
Purity : >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 42 | In Stock |
|
| 10MG | 60 | In Stock |
|
| 50MG | 78 | In Stock |
|
| 100MG | 114 | In Stock |
|
| 200MG | 141 | In Stock |
|
| 500MG | 294 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePalbociclib (PD0332991) Isethionate
-
NoteResearch use only, not for human use.
-
Brief DescriptionPalbociclib (PD0332991) Isethionate is a highly selective inhibitor of CDK4/6 with IC50 of 11 nM/16 nM.
-
DescriptionPalbociclib (PD0332991) Isethionate is a highly selective inhibitor of CDK4/6 with IC50 of 11 nM/16 nM. It shows no activity against CDK1/2/5, EGFR, FGFR, PDGFR, InsR, etc. Phase 3.
-
Synonyms——
-
PathwayAngiogenesis
-
TargetCDK
-
RecptorCDK2/CyclinA; CDK2/CyclinE2; CDK4/CyclinD1; CDK4/CyclinD3; CDK6/CyclinD2
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number827022-33-3
-
Formula Weight573.66
-
Molecular FormulaC24H29N7O2·C2H6O4S
-
Purity>98%(HPLC)
-
SolubilityWater: 50 mg/mL warmed (87.15 mM)
-
SMILESOCCS(O)(=O)=O.CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Fry DW, et al. Mol Y Ther, 2004, 3(11), 1427-1438.
molnova catalog
related products
-
CDK4/6-IN-2
CDK4/6-IN-2 is a potent CDK4 and CDK6 inhibitor (IC50s: 2.7 and 16 nM) extracted from patent US20180000819A1 (Compound 1).
-
R-547
A potent, selective and ATP-competitive CDK inhibitor with Ki of 1/3/1 nM for CDK1/2/4, respectively.
-
BSJ-4-116
BSJ-4-116 is a highly potent and selective CDK12 degrader (PROTAC) with an IC50 of 6 nM.?It downregulates DDR genes through a premature termination of transcription, primarily through increasing poly(adenylation).
